Rare diseases
Investigational molecules
Locations
Back to France651 clinical trials in Clermont Ferrand, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease
FranceA study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy
FranceA study of mRNA-4157 and a drug combination for patients with stage IV non-small cell lung cancer
FranceA study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer
FranceA study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.
FranceStudy of AMO959, lutetium (177Lu) vipivotide tetraxetan, and a drug combination for adults with advanced prostate cancer.
FranceA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
FranceA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
FranceStudy of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
FranceEvaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study
FrancePhase 1b-2 Study of Elacestrant and Abemaciclib in Patients with Brain Metastases from ER-Positive, HER2-Negative Breast Cancer
FranceA study testing prednisone combined with antibiotics compared to antibiotics alone in adults with septic arthritis to improve joint health
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on inflammatory bowel diseases including groundbreaking trials examining fecal microbiota transplantation in both Crohn's disease and ulcerative colitis. Research aims to evaluate new therapeutic approaches for patients with moderate to severe conditions.
These trials are exploring alternative treatment pathways for patients who have not responded to conventional therapies.
Comprehensive research in multiple myeloma and various cancer types, including innovative treatments for esophageal squamous cell carcinoma and pleural mesothelioma. Studies evaluate new therapeutic combinations and maintenance strategies.
Focus on improving patient outcomes through targeted therapies and immunological approaches.
Advanced research into rheumatoid arthritis and multiple sclerosis, investigating optimized treatment protocols and maintenance therapies. Studies aim to improve long-term disease management and patient quality of life.
Emphasis on developing more effective and tolerable treatment regimens.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
